Human MARCHF9/MARCH-IX/MARCH9 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_138396)

Cat. No.: pGMAAV001219
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human MARCHF9/MARCH-IX/MARCH9 Adeno-associated virus expression plasmid (ITR-vector) for MARCHF9 AAV packaging, MARCHF9 AAV production.The purified Human MARCHF9/MARCH-IX/MARCH9 AAV particle serves as an invaluable asset for in-depth in vivo MARCHF9 studies, mechanism of action (MOA) research, and the evolution of MARCHF9-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV001219
Gene Name MARCHF9
Accession Number NM_138396
Gene ID 92979
Species Human
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 1041 bp
Gene Alias MARCH-IX,MARCH9,RNF179
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CTNT
Resistance Amplicin
ORF Nucleotide Sequence ATGCTCAAGTCTCGGCTCCGCATGTTTCTGAACGAGCTGAAGCTGCTGGTGCTGACAGGCGGGGGGCGGCCCCGGGCCGAGCCGCAACCCCGGGGGGGCCGGGGAGGCGGCTGCGGCTGGGCGCCCTTCGCTGGCTGCTCCACCCGGGACGGCGACGGCGACGAGGAGGAGTACTACGGGTCGGAGCCGCGGGCCCGGGGCCTGGCCGGCGACAAGGAGCCGCGGGCCGGACCCCTGCCGCCGCCCGCGCCGCCGCTGCCGCCCCCGGGCGCGCTGGACGCCCTGTCGCTCAGCAGTAGCCTGGACAGCGGACTCCGAACCCCTCAGTGCCGGATCTGCTTCCAGGGCCCGGAGCAGGGGGAGCTCTTAAGCCCCTGCCGCTGCGACGGCTCAGTGCGCTGCACGCATCAGCCCTGCCTCATCCGCTGGATCAGCGAGAGGGGCTCCTGGAGCTGTGAGCTCTGCTACTTCAAGTACCAGGTCCTGGCGATCAGCACCAAGAACCCACTGCAGTGGCAGGCCATCTCCCTGACGGTCATCGAGAAGGTCCAGATTGCTGCCATAGTTCTGGGCTCGCTCTTCCTGGTTGCCAGCATCTCCTGGCTCATCTGGTCCTCACTCAGCCCTTCAGCCAAGTGGCAACGACAGGATCTGCTCTTTCAGATCTGCTACGGCATGTATGGCTTCATGGATGTCGTCTGCATAGGCCTCATCATCCATGAAGGCTCCTCTGTCTACCGCATCTTCAAGCGCTGGCAGGCAGTGAACCAGCAGTGGAAGGTCCTAAATTATGACAAGACCAAGGACATAGGAGGAGATGCAGGGGGAGGGACGGCAGGGAAGTCAGGCCCCAGGAACTCACGGACGGGCCCCACCTCTGGGGCCACGAGCCGCCCCCCAGCTGCCCAGCGCATGCGGACGCTCTTGCCTCAGCGCTGCGGTTATACAATCTTGCACCTCCTTGGGCAGCTGCGGCCACCAGATGCCCGTTCCAGCTCCCATTCTGGCCGAGAGGTTGTCATGAGGGTCACTACAGTCTGA
ORF Protein Sequence MLKSRLRMFLNELKLLVLTGGGRPRAEPQPRGGRGGGCGWAPFAGCSTRDGDGDEEEYYGSEPRARGLAGDKEPRAGPLPPPAPPLPPPGALDALSLSSSLDSGLRTPQCRICFQGPEQGELLSPCRCDGSVRCTHQPCLIRWISERGSWSCELCYFKYQVLAISTKNPLQWQAISLTVIEKVQIAAIVLGSLFLVASISWLIWSSLSPSAKWQRQDLLFQICYGMYGFMDVVCIGLIIHEGSSVYRIFKRWQAVNQQWKVLNYDKTKDIGGDAGGGTAGKSGPRNSRTGPTSGATSRPPAAQRMRTLLPQRCGYTILHLLGQLRPPDARSSSHSGREVVMRVTTV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV001219 Human MARCHF9 Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.